Staar Surgical (STAA) Receivables (2010 - 2026)

Staar Surgical (STAA) has reported Receivables for 17 consecutive years, with $98.5 million the latest figure, recorded in Q3 2026.

• For the quarter ending Q3 2026, Receivables rose 185.93% year-over-year to $98.5 million; the trailing twelve-month figure through Jul 2026 stood at $98.5 million (up 185.93% YoY), and the FY2026 full-year result was $50.4 million, down 52.15% from the prior year.
• Receivables climbed to $98.5 million in Q3 2026 per STAA's latest filing, from $81.2 million in the prior quarter.
• Across five years, Receivables topped out at $112.4 million in Q3 2023 and bottomed at $34.4 million in Q2 2025.
• Historically, Receivables has averaged $72.1 million across 5 years, with a median of $64.0 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Receivables slumped 63.28% in 2025, then surged 185.93% in 2026.
• Over 5 years, Receivables stood at $62.5 million in 2022, then soared by 51.9% to $94.9 million in 2023, then retreated by 17.88% to $77.9 million in 2024, then dropped by 22.88% to $60.1 million in 2025, then surged by 63.84% to $98.5 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $98.5 million, $81.2 million, and $50.4 million for Q3 2026, Q2 2026, and Q1 2026 respectively.